This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.
Company Profile:
Vor Biopharma, Inc.
Market Cap (USD):
$61.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Surface Oncology, Inc.
Market Cap (USD):
$59.2 M
(July 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Anebulo Pharmaceuticals, Inc.
Market Cap (USD):
$58.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Passage Bio, Inc.
Market Cap (USD):
$56.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
HOOKIPA Pharma Inc.
Market Cap (USD):
$55.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Artemis Therapeutics, Inc.
Market Cap (USD):
$55.8 M
(May 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cidara Therapeutics, Inc.
Market Cap (USD):
$55.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Eyenovia, Inc.
Market Cap (USD):
$53.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Tyme Technologies, Inc.
Market Cap (USD):
$53.5 M
(Sept. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Sigilon Therapeutics, Inc.
Market Cap (USD):
$53.3 M
(July 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ovid Therapeutics Inc.
Market Cap (USD):
$52.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Reneo Pharmaceuticals, Inc.
Market Cap (USD):
$50.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aeglea BioTherapeutics, Inc.
Market Cap (USD):
$48.6 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BioVie Inc.
Market Cap (USD):
$48.3 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cue Biopharma, Inc.
Market Cap (USD):
$46.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cyclo Therapeutics, Inc.
Market Cap (USD):
$45.2 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Fortress Biotech, Inc.
Market Cap (USD):
$44.5 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Lantern Pharma Inc.
Market Cap (USD):
$44.4 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Eledon Pharmaceuticals, Inc.
Market Cap (USD):
$44.3 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Atara Biotherapeutics, Inc.
Market Cap (USD):
$44.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Dyadic International, Inc.
Market Cap (USD):
$44.2 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Rain Therapeutics, Inc.
Market Cap (USD):
$43.7 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Kezar Life Sciences, Inc.
Market Cap (USD):
$42.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ocuphire Pharma, Inc.
Market Cap (USD):
$39.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BioXcel Therapeutics, Inc.
Market Cap (USD):
$39.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Curis, Inc.
Market Cap (USD):
$37.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aligos Therapeutics, Inc.
Market Cap (USD):
$37.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BeyondSpring Inc.
Market Cap (USD):
$36.2 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Reviva Pharmaceuticals Holdings, Inc.
Market Cap (USD):
$35.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Longeveron, Inc.
Market Cap (USD):
$32.4 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology